9928 Federal Register / Vol. 62, No. 43 / Wednesday, March 5, 1997 / Rules and Regulations

§ 39.13 [Amended]

2. Section 39.13 is amended by

adding the following new airworthiness

directive:

97–05–09 Boeing: Amendment 39–9953.

Docket 96–NM–146–AD.

Applicability: Model 737 series airplanes

equipped with an aileron or elevator power

control unit (PCU) having part number (P/N)

65–45180–29, serial numbers 182 through

1297 inclusive; certificated in any category.

Note 1: Originally, aileron or elevator

PCU’s having P/N’s and serial numbers

identified in the applicability of this AD may

have been installed on Model 737 series

airplanes having line numbers 1793 through

2036 inclusive. In addition, some of these

PCU’s may have been used as spares;

therefore, specific airplane line numbers

equipped with such PCU’s cannot be

provided in this AD.

Note 2: PCU’s having P/N 65–45180–29

consist of a PCU assembly having P/N 65–

44761–21 plus associated hydraulic fittings.

Both PCU P/N’s 65–45180–29 and 65–44761–

21 are serialized. PCU’s subject to the

requirements of this AD may be more easily

identified using serial numbers for P/N 65–

44761–21. The following serial numbers

correspond to P/N 65–44761–21:

8550A,

8552A,

8556A,

8557A,

8561A,

8563A through 8718A inclusive,

8720A through 8726A inclusive,

8728A through 8745A inclusive,

8749A,

8750A through 8758A inclusive,

8760A through 8873A inclusive,

8876A through 9004A inclusive,

9007A through 9012A inclusive,

9014A through 9040A inclusive,

9042A through 9066A inclusive,

9068A through 9340A inclusive,

9342A through 9388A inclusive,

9390A through 9529A inclusive,

9531A through 9676A inclusive, and

9678A through 9688A inclusive.

Note 3: This AD applies to each airplane

identified in the preceding applicability

provision, regardless of whether it has been

otherwise modified, altered, or repaired in

the area subject to the requirements of this

AD. For airplanes that have been modified,

altered, or repaired so that the performance

of the requirements of this AD is affected, the

owner/operator must request approval for an

alternative method of compliance in

accordance with paragraph (c) of this AD.

The request should include an assessment of

the effect of the modification, alteration, or

repair on the unsafe condition addressed by

this AD; and, if the unsafe condition has not

been eliminated, the request should include

specific proposed actions to address it.

Compliance: Required as indicated, unless

accomplished previously.

To prevent reduced roll and/or pitch rate

control of the aileron and consequent

increased pilot workload, accomplish the

following:

(a) Within 5 years or 15,000 flight hours

after the effective date of this AD, whichever

occurs first: Replace the four flow restrictors,

part number (P/N) JETA1875500D, on the

aileron and elevator power control units

(PCU’s), P/N 65–45180–29, serial numbers

182 through 1297 inclusive, with flow

restrictors having P/N JETX0527100B, in

accordance with Boeing Service Letter 737-

SL–27–71–A, dated June 19, 1992, including

Attachment 1.

(b) As of the effective date of this AD, no

person shall install a flow restrictor having

P/N JETA1875500D on an aileron or elevator

PCU having P/N 65–45180–29, serial

numbers 182 through 1297 inclusive, of any

airplane.

(c) An alternative method of compliance or

adjustment of the compliance time that

provides an acceptable level of safety may be

used if approved by the Manager, Seattle

Aircraft Certification Office (ACO), FAA,

Transport Airplane Directorate. Operators

shall submit their requests through an

appropriate FAA Principal Maintenance

Inspector, who may add comments and then

send it to the Manager, Seattle ACO.

Note 4: Information concerning the

existence of approved alternative methods of

compliance with this AD, if any, may be

obtained from the Seattle ACO.

(d) Special flight permits may be issued in

accordance with sections 21.197 and 21.199

of the Federal Aviation Regulations (14 CFR

21.197 and 21.199) to operate the airplane to

a location where the requirements of this AD

can be accomplished.

(e) The replacement shall be done in

accordance with Boeing Service Letter 737–

SL–27–71–A, dated June 19, 1992, including

Attachment 1. This incorporation by

reference was approved by the Director of the

Federal Register in accordance with 5 U.S.C.

552(a) and 1 CFR part 51. Copies may be

obtained from Boeing Commercial Airplane

Group, P.O. Box 3707, Seattle, Washington

98124–2207. Copies may be inspected at the

FAA, Transport Airplane Directorate, 1601

Lind Avenue, SW., Renton, Washington; or at

the Office of the Federal Register, 800 North

Capitol Street, NW., suite 700, Washington,

DC.

(f) This amendment becomes effective on

April 9, 1997.

Issued in Renton, Washington, on February

25, 1997.

James V. Devany,

Acting Manager, Transport Airplane

Directorate, Aircraft Certification Service.

[FR Doc. 97–5158 Filed 3–4–97; 8:45 am]

BILLING CODE 4910–13–U

14 CFR Part 71

[Airspace Docket No. 93–AEA–02]

Amendment to Class E Airspace;

Dunkirk, NY

AGENCY: Federal Aviation

Administration (FAA) DOT.

ACTION: Final rule.

SUMMARY: This amendment modifies the

Class E airspace at Dunkirk, NY, to

accommodate a Global Positioning

System (GPS) Standard Instrument

Approach Procedure (SIAP) to Runway

(RWY) 19 and a VHF Omni-Directional

Radio Range/Distance Measuring

Equipment (VOR/DME) SIAP to at

Angola Airport. The intended effect of

this action is to provide adequate

controlled airspace for instrument flight

rules (IFR) operations at the airport.

EFFECTIVE DATE: 0901 UTC, May 22,

1997.

FOR FURTHER INFORMATION CONTACT: Mr.

Francis Jordan, Airspace Specialist,

Operations Branch, AEA–530, Air

Traffic Division, Eastern Region, Federal

Aviation Administration, Federal

Building # 111, John F. Kennedy

International Airport, Jamaica, New

York 11430, telephone: (718) 553–4521.

SUPPLEMENTARY INFORMATION:

History

On January 6, 1995, the FAA

proposed to amend Part 71 of the

Federal Aviation Regulations (14 CFR

Part 71) by modifying Class E airspace

at Dunkirk, NY, (60 FR 2047). This

action would provide adequate Class E

airspace for IFR operations at Angola

Airport.

Interested parties were invited to

participate in this rulemaking

proceeding by submitting written

comments on the proposal to the FAA.

No comments objecting to the proposal

were received.

Class E airspace areas designations are

published in paragraph 6005 of FAA

Order 7400.9D, dated September 4,

1996, and effective September 16, 1996,

which is incorporated by reference in 14

CFR 71.1. The Class E airspace

designation listed in this document will

be published subsequently in the Order.

The Rule

This amendment to part 71 of the

Federal Aviation Regulations (14 CFR

part 71) modifies Class E airspace area

at Dunkirk, NY, to accommodate a GPS

RWY 19 SIAP, a VOR/DME or GPS A

SIAP and for IFR operations at Angola

Airport.

The FAA has determined that this

regulation only involves an established

body of technical regulations for which

frequent and routine amendments are

necessary to keep them operationally

current. Therefore, this regulation—(1)

is not a ‘‘significant regulatory action’’

under Executive Order 12866; (2) is not

a ‘‘significant rule’’ under DOT

Regulatory Policies and Procedures (44

FR 10034; February 26, 1979); and (3)

does not warrant preparation of a

regulatory evaluation as the anticipated

impact is so minimal. Since this is a
Federal Register / Vol. 62, No. 43 / Wednesday, March 5, 1997 / Rules and Regulations 9929

routine matter that will only affect air

traffic procedures and air navigation it

is certified that this rule will not have

significant economic impact on a

substantial number of small entities

under the criteria of the Regulatory

Flexibility Act.

List of Subjects in 14 CFR Part 71

Airspace, Incorporation by reference,

Navigation (air).

Adoption of the Amendment

In consideration of the foregoing, the

Federal Aviation Administration

amends 14 CFR part 71 as follows:

PART 71—[AMENDED]

1. The authority citation for 14 CFR

Part 71 continues to read as follows:

Authority: 49 U.S.C. 106(g), 40103, 40113,

40120; EO 10854, 24 FR 9565, 3 CFR, 1959–

1963 Comp., p. 389; 14 CFR 11.69.

§ 71.1 [Amended]

2. The incorporation by reference in

14 CFR 71.1 of Federal Aviation

Administration Order 7400.9D, Airspace

Designation and Reporting Points, dated

September 4, 1996, and effective

September 16, 1996, is amended as

follows:

Paragraph 6005 Class E airspace areas

extending upward from 700 feet or more

above the surface of the earth.

* * * * *

AEA NY AEA E5 Dunkirk, NY [Revised]

Chautauqua County/Dunkirk Airport, NY

(Lat. 42°29′36′′ N., long. 79°16′19′′ W.)

Angola Airport, NY

(Lat. 42°39′37′′ N., long. 78°59′28′′ W.)

Dunkirk VORTAC, NY

(Lat. 42°29′26′′ N., long. 79°16′27′′ W.)

That airspace extending upward from 700

feet above the surface within a 6.6-mile

radius of Chautauqua County/Dunkirk

Airport and within 11.8-mile radius of the

airport extending clockwise from a 022° to a

264° bearing from the airport and within a

6.3 mile radius of the Angola Airport and

within 5.3 miles northwest of 051° radial

from the Dunkirk VORTAC and within 5.3

miles northwest of the 231° radial from the

VORTAC extending from the 6.3-mile radius

to 9.9 miles southwest of the VORTAC.

* * * * *

Issued in Jamaica, New York on February

21, 1997.

James K. Buckles,

Acting Manager, Air Traffic Division, Eastern

Region.

[FR Doc. 97–5436 Filed 3–4–97; 8:45 am]

BILLING CODE 4910–13–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Food and Drug Administration

21 CFR Part 558

New Animal Drugs for Use in Animal

Feeds; Laidlomycin Propionate

Potassium

AGENCY: Food and Drug Administration,

HHS.

ACTION: Final rule.

SUMMARY: The Food and Drug

Administration (FDA) is amending the

animal drug regulations to reflect

approval of a supplemental new animal

drug application (NADA) filed by

Hoffmann-LaRoche, Inc. The

supplemental NADA provides for use of

dry laidlomycin propionate potassium

Type A articles for making liquid Type

B medicated feeds used to make dry

Type C medicated feeds. The Type C

feeds are for cattle fed in confinement

for slaughter for increased rate of weight

gain and improved feed efficiency.

EFFECTIVE DATE: March 5, 1977.

FOR FURTHER INFORMATION CONTACT:

Russell G. Arnold, Center for Veterinary

Medicine (HFV–142), Food and Drug

Administration, 7500 Standish Pl.,

Rockville, MD 20855, 301–594–1674.

SUPPLEMENTARY INFORMATION: HoffmannLaRoche, Inc., Nutley, NJ 07110, filed

supplemental NADA 141–025, which

provides for use of Cattylyst 50 (50

grams (g) per pound laidlomycin

propionate potassium) dry Type A

articles to make liquid, 100 to 2,000 g

per ton (g/t) laidlomycin propionate

potassium Type B feeds, used to make

dry, 5 to 10 g/t laidlomycin propionate

potassium Type C feeds. The Type C

feeds are for cattle fed in confinement

for slaughter for increased rate of weight

gain and improved feed efficiency. The

supplemental NADA is approved as of

March 5, 1997, and § 558.305 (21 CFR

558.305) is amended to reflect the

approval.

In addition, certain mixing directions

for liquid feeds are required for use of

laidlomycin propionate potassium

liquid Type B feeds to make Type C

feeds. Those directions had not been

previously codified in the regulation. At

this time, existing § 558.305(b) is

redesignated as § 558.305(d) and new

paragraph (b) is added to include those

directions. New § 558.305(c) is

established and reserved for future use.

The supplement is for a new

formulation of an approved product

used to make another approved product.

Approval does not affect the basis of

approval or the conditions of use of the

currently approved application. No

additional safety or effectiveness data

are required. Therefore, a freedom of

information summary is not required. A

summary of safety and effectiveness

data and information submitted to

support approval of the original

application may be seen in the Dockets

Management Branch (HFA–305), Food

and Drug Administration, 12420

Parklawn Dr., rm. 1–23, Rockville, MD

20857, between 9 a.m. and 4 p.m.,

Monday through Friday.

Under section 512(c)(2)(F)(iii) of the

Federal Food, Drug, and Cosmetic Act

(21 U.S.C. 360b(c)(2)(F)(iii)), this

approval does not qualify for marketing

exclusivity because the supplement

does not contain substantial evidence of

effectiveness of the drugs involved, any

studies of animal safety or, in the case

of food-producing animals, human food

safety studies (other than

bioequivalence or residue studies)

required for approval and conducted or

sponsored by the applicant.

The agency has determined under 21

CFR 25.24(d)(1)(iii) that this action is of

a type that does not individually or

cumulatively have a significant effect on

the human environment. Therefore,

neither an environmental assessment

nor an environmental impact statement

is required.

List of Subjects in 21 CFR Part 558

Animal drugs, Animal feeds.

Therefore, under the Federal Food,

Drug, and Cosmetic Act and under

authority delegated to the Commissioner

of Food and Drugs and redelegated to

the Center for Veterinary Medicine, 21

CFR part 558 is amended as follows:

PART 558—NEW ANIMAL DRUGS FOR

USE IN ANIMAL FEEDS

1. The authority citation for 21 CFR

part 558 continues to read as follows:

Authority: Secs. 512, 701 of the Federal

Food, Drug, and Cosmetic Act (21 U.S.C.

360b, 371).

2. Section 558.305 is amended by

redesignating paragraph (b) as paragraph

(d), by adding new paragraphs (b) and

(c), and by revising the title of

redesignated paragraph (d)(3) to read as

follows:

§ 558.305 Laidlomycin propionate

potassium.

* * * * *

(b) Special considerations. (1)

Laidlomycin liquid Type B feeds may be

manufactured from dry laidlomycin

Type A articles. The liquid Type B feeds

must have a pH of 6.0 to 8.0, dry matter

of 62 to 75 percent, and bear appropriate

mixing directions as follows: